Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_7_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_3_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_1_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_6_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_4_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_8_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_2_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Image_9_Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.pdf by Sung-Hee Kim (11271393)

“…After inoculation of 10⁵ PFU of SARS-CoV-2 to the K18-hACE2, SFTPB-hACE2, and SCGB1A1-hACE2 models, the peak viral titer was detected at 2 days post-infection and then gradually decreased. …”

Summary of demographics for all cohorts. by Emily Baker (3492485)

“…Variability in the estimation of SNP-based heritability could explain the differences in reported heritability.</p><p>Methods</p><p>We compute heritability in five large independent cohorts (N = 7,396, 1,566, 803, 12,528 and 3,963) to determine whether a consensus for the AD heritability estimate can be reached. …”

S1 Data - by Emily Baker (3492485)

“…Variability in the estimation of SNP-based heritability could explain the differences in reported heritability.</p><p>Methods</p><p>We compute heritability in five large independent cohorts (N = 7,396, 1,566, 803, 12,528 and 3,963) to determine whether a consensus for the AD heritability estimate can be reached. …”

CA-induced MTT and crystal violet reduction and protection by Ber in N2a cells. by Xiaofeng Liu (35910)

“…<p>CA decreased cell viability in a dose-dependent manner as determined by MTT and crystal violet assay (<b>A</b>) and Ber increased cell viability in a dose-dependent manner until to 25 μg/ml in 2.5 nmol/L CA-treated cells (<b>B</b>). 25 μg/ml Ber showed significant protection of the cells from CA-induced lesions. …”

Diagnostic criteria for PMDD according to DSM5, and algorithm used to assess PMDD status using the PAF-shortened form. by Déborah Ducasse (849628)

“…<p><i>To calculate PMDD diagnoses with the PAF we followed the DSM criteria as closely as possible</i>. …”

DataSheet1_The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reportin... by Anke Salmen (5321717)

“…CFRs at different vaccination coverage levels were then compared to CFRs before vaccination campaign start.</p><p>Results: While we found an overall decrease in CFRs on population level with increasing vaccination coverage, we found no decrease in people using anti-CD20 or glucocorticoids.…”

Effect of Oxidative Phosphorylation Inhibitors on <i>In Vivo</i> Tat Transport and Sensitivity of Fluorescence Detection on Plates. by Umesh K. Bageshwar (2271628)

“…Valinomycin (V; 50 μM) is a K⁺ ionophore, which collapses the Δψ. …”

MiRNA-124 transfection induces apoptosis in UKF-NB-MV cells. by Hila Naaman (4538170)